Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Ceftriaxone/Metronidazole for SSI Prophylaxis in Colorectal Surgery
NCT01254344Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ertapenem in surgical site infection (SSI), sponsored by Merck & Co.. Started Dec 2010; status: completed.
02
Drugs
ertapenem
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01254344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254344.